- Home
- ACET vs PHUN Comparison
ACET vs PHUN Comparison
Compare ACET & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- PHUN
- Stock Information
- Founded
- ACET 1947
- PHUN 2009
- Country
- ACET United States
- PHUN United States
- Employees
- ACET N/A
- PHUN N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- PHUN EDP Services
- Sector
- ACET Health Care
- PHUN Technology
- Exchange
- ACET Nasdaq
- PHUN Nasdaq
- Market Cap
- ACET 70.3M
- PHUN 62.1M
- IPO Year
- ACET N/A
- PHUN N/A
- Fundamental
- Price
- ACET $0.67
- PHUN $2.78
- Analyst Decision
- ACET Buy
- PHUN Buy
- Analyst Count
- ACET 6
- PHUN 2
- Target Price
- ACET $6.00
- PHUN $8.00
- AVG Volume (30 Days)
- ACET 312.0K
- PHUN 299.2K
- Earning Date
- ACET 03-06-2025
- PHUN 05-08-2025
- Dividend Yield
- ACET N/A
- PHUN N/A
- EPS Growth
- ACET N/A
- PHUN N/A
- EPS
- ACET N/A
- PHUN N/A
- Revenue
- ACET N/A
- PHUN $3,189,000.00
- Revenue This Year
- ACET N/A
- PHUN $98.49
- Revenue Next Year
- ACET N/A
- PHUN N/A
- P/E Ratio
- ACET N/A
- PHUN N/A
- Revenue Growth
- ACET N/A
- PHUN N/A
- 52 Week Low
- ACET $0.67
- PHUN $2.70
- 52 Week High
- ACET $2.40
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- ACET 32.94
- PHUN 38.29
- Support Level
- ACET $0.74
- PHUN $2.82
- Resistance Level
- ACET $0.91
- PHUN $3.06
- Average True Range (ATR)
- ACET 0.06
- PHUN 0.17
- MACD
- ACET -0.01
- PHUN 0.03
- Stochastic Oscillator
- ACET 0.36
- PHUN 3.80
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States.